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Abstract
The lipid content of cultured cells can be experimentally modified by supplementing the culture medium with specific lipids
or by the use of phospholipases. In the case of the insulin receptor, these methods have contributed to a better understanding
of lipid disorder-related diseases. Previously, our laboratory demonstrated that experimental modification of the cellular lipid
composition of an insulin-sensitive rat hepatoma cell line (ZHC) resulted in an alteration in insulin receptor binding and
biological action (Bruneau et al., Biochim. Biophys. Acta 928 (1987) 287^296/297^304). In this paper, we have examined the
effects of lipid modification in another hepatoma cell line, HepG2. Exogenous linoleic acid (LA, n^6), eicosapentaenoic acid
(EPA, n^3) or hemisuccinate of cholesterol (CHS) was added to HepG2 cells, to create a cellular model in which membrane
composition was modified. In this model, we have shown that: (1) lipids were incorporated in treated HepG2 cells, but
redistributed differently when compared to treated ZHC cells ; (2) that insulin signaling events, such as insulin receptor
autophosphorylation and the phosphorylation of the major insulin receptor substrate (IRS-1) were altered in response to the
addition of membrane lipids or cholesterol derived components; and (3) different lipids affected insulin receptor signaling
differently. We have also shown that the loss of insulin receptor autophosphorylation in CHS-treated cells can be correlated
with a decreased sensitivity to insulin. Overall, the results suggest that the lipid environment of the insulin receptor may play
an important role in insulin signal transduction. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The lipid content of cultured cell membranes can
be modi¢ed by supplementing the culture medium
with speci¢c lipids or by the use of phospholipases.
Both methods have been used to study lipid e¡ects
on receptor signaling, including e¡ects on the insulin
receptor (IR) [1], the epidermal growth factor recep-
tor [2] and the Na,K-ATPase channel [3]. For ex-
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Abbreviations: BSA, bovine serum albumin; CHS, cholesterol
hemisuccinate; DMEM, Dulbecco’s modi¢ed Eagle’s medium;
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calf serum; IR, insulin receptor; KRB, Krebs^Ringer bu¡er;
LA, linoleic acid; MAPK, mitogen-activated protein kinase;
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ample, alteration in the lipid composition of Friend
erythroleukemia cells [4] and Ehrlich ascites cells [5]
by supplementing culture medium with lipids,
showed that a high percentage of unsaturated fatty
acids was associated with an increase in insulin re-
ceptor number and a decrease in binding receptor
a⁄nity. Other studies on membrane lipid composi-
tion have shown that the lipid environment of the
receptor can a¡ect the insulin signaling system
[6,7]. These e¡ects may be observed at the level of
tyrosine kinase activity [8,9] or later in the signaling
pathways involved in insulin-dependent biological
actions. Insulin events can be modulated by the lipid
environment of the receptor in vitro [10,11] and in
intact cells [7,12]. Nevertheless, lipid e¡ects on insu-
lin receptor signaling are poorly understood and
need to be further examined.
Insulin signal transduction pathways are well
documented. Insulin binds to a speci¢c heterotetra-
meric membrane receptor (K2L2) which possess an
intracellular tyrosine kinase activity. Kinase activa-
tion after oligomerization of the receptor leads to the
phosphorylation of the L-subunit on tyrosine resi-
dues (autophosphorylation of the receptor) allowing
cytoplasmic proteins containing SH2/SH3 domains
(src homology) or plekstrin domains [13] to bind
directly to the phosphorylated tyrosine sequence of
the intracellular part of the receptor. Insulin receptor
substrate-1 (IRS-1) is one of the best understood
substrates of the receptor [14] and has been impli-
cated in the initiation of several biological pathways,
such as the pathway for glycogen synthesis [15].
In the present study, we investigated the possibility
that lipids could modulate insulin signal transduction
in a human hepatoma cell line, HepG2. This cell line
has retained several properties of human hepatocytes
[16] and possess functional insulin receptors. Insulin
exerts metabolic actions on HepG2 cells, including
e¡ects on lipogenesis, glycogen synthesis and triacyl-
glycerol synthesis [17]. By supplementing the culture
medium of HepG2 cells with linoleic acid (LA, n^6),
eicosapentaenoic acid (EPA, n^3) or a cholesterol
derivative, hemisuccinate of cholesterol (CHS), we
were able to develop a cellular model in which mem-
brane composition was altered. These lipids were
chosen because of their involvement in pathological
disorders, such as arteriosclerosis, cardiovascular dis-
ease, diabetes and cancer [18^20]. Insulin binding, IR
autophosphorylation, IRS-1 phosphorylation and
downstream signaling events, such as glycogenesis,
were analyzed in both control and lipid-treated cells.
2. Materials and methods
2.1. Materials
Bovine insulin was a gift from Lily (Indianapolis,
USA). Horseradish-linked peroxidase antibodies and
chemiluminescence detection kit (ECL) were ob-
tained from Amersham (Les Ulis, France). Choles-
terol hemisuccinate was obtained from Sigma (St
Louis, MO). Antiphosphotyrosine (monoclonal,
clone 4G10) antibodies were purchased from UBI
(Lake Placid, USA). Dulbelcco’s modi¢ed Eagle’s
medium (DMEM) and fetal calf serum (FCS) were
purchased from Gibco (Grand Island, NY, USA).
All other chemicals and reagents were of analytical
grade.
2.2. Cell culture
Hepatocarcinoma HepG2 cells were obtained from
ATCC (Rockville, MD, USA). Cells were grown in
monolayer, in 75 cm2 plastic tissue culture £asks or
in 12-well plates for all experiments, in DMEM sup-
plemented with 10% FCS, 4.5 g/l glucose, 100 U/ml
penicillin and 100 mg/ml streptomycin under a 5%
CO2 atmosphere. To alter the lipid composition of
the cells, monolayers were grown for two to four
passages in culture medium supplemented with chol-
esterol hemisuccinate (1034 M), linoleic acid (LA,
1034 M) or eicosapentaenoic acid (EPA, 1035 M).
At higher lipid concentrations, cell viability, esti-
mated by lactate dehydrogenase tests, decreased
and the lipids were shown to be toxic. All experi-
ments were performed during the exponential phase
of growth.
2.3. Analysis of lipid composition and membrane
£uidity
For lipid analysis, con£uent cell monolayers were
rinsed three times in 0.9 g/l NaCl and resuspended in
isobutanol. Lipids were extracted in chloroform/
methanol according to Leray et al. [21]. The choles-
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terol content was estimated by the colorimetric meth-
od using FeCl3 and H2SO4 [22]. Lipid extraction was
performed according to the Folch technique [23].
For membrane £uidity measurements, cells were
seeded into 60-mm dishes in DMEM/10% FCS in
the presence or absence of the di¡erent lipids until
they reached con£uency. Cells were transferred to
DMEM for 16 h. Membrane £uidity was determined
at 25‡C on freshly scraped and suspended cells as
£uorescence polarization of trimethylammonium di-
phenylhexatriene (TMA-DPH) (1 WM) and diphenyl-
hexatriene (DPH) (1 WM), as described by Bruneau
et al. [12]. Fluidity was measured by the £uorescence
polarization of the two probes using an AMINCO
SPF 500 equipped with polarization measurement
accessories.
2.4. Insulin binding
Measurement of [125I]insulin (3-[125I]iodotyrosyl
A14 insulin, speci¢c activity: 74 Tbq/mmol; 2000
Ci/mmol), binding was carried out according to pre-
viously described methods [12]. Brie£y, cells were in-
cubated for 16 h in DMEM. Then monolayers were
rinsed twice with PBS. Five hundred microliters of
binding bu¡er (100 mM HEPES pH 7,6, 150 mM
NaCl, 1.2 mM MgSO4, 5 mM KCl, 10 mM glucose,
15 mM sodium acetate, 0.1% CaCl2, 0.1% bovine
serum albumin), 25 Wl of unlabeled peptide at di¡er-
ent concentrations and 25 Wl of [125I]insulin (20 000^
40 000 cpm) were added to each well. The plates were
then incubated at 16‡C for 4 h. The plates were
washed two times with Krebs^Ringer bu¡er (KRB;
0.9% NaCl, 1.15% KCl, 2.1% KH2PO4, 3.8%
MgSO4, 0.2 M Na-pyruvate, 0.1 M Na-fumarate,
0.1 M Na-glutamate, 0.3 M glucose, pH 7,4) and
lysed in NaOH 0.2 N. Aliquots were removed for
protein determination by the method of Bradford
[24] using BSA as a standard. Radioactivity of the
cell solute was determined in a gamma counter at
76% e⁄ciency (LKB-Wallac 1260). All points were
determined in triplicate for a minimum of three sep-
arate experiments.
2.5. Incorporation of 14C-glucose into glycogen
Glycogen synthesis from uniformly labeled D-[14C]-
glucose (D[U-14C]glucose, speci¢c activity: 11 GBq/
mmol; 295 mCi/mmol), was determined as described
by Staedel-Flaig and Beck [25]. Brie£y, cells were
incubated for 16 h in Ham F12 medium containing
1 g/l of glucose. Stimulation of the cells with insulin
(concentrations ranging from 1037 to 10311 M) was
performed for 2 h at room temperature in PBS con-
taining 0.1 g/l CaCl2 ; 0.1 g/l MgCl2 ; 1 g/l BSA;
4 WCi/well [14C]glucose and 5 mM glucose. After
washing the plates three times with ice-cold KRB,
500 Wl of 30% KOH was added to each well for
30 min at 37‡C. Glycogen was further precipitated
by 10% Na2SO4/EtOH for 16 h at 320‡C. After
centrifugation, the pellets were washed once in ice
cold EtOH, solubilized in 500 Wl H2O and counted.
2.6. Immunoblotting with antiphosphotyrosine
antibodies
Cells were seeded into 12-well plates in DMEM/
10% FCS and transferred to DMEM without FCS.
Cells were then stimulated with insulin. Incubation
was stopped by aspirating the medium, instantly
freezing the cells and extracting them in a 1:1 mix
of lysis bu¡er (20 mM Tris, 1% Triton X-100,
137 mM NaCl, 1 mM NaVo4) and Laemli sample
bu¡er [26]. Lysates were boiled for 5 min and ana-
lyzed by electrophoresis on 7.5% acrylamide gels.
Proteins were electrophoretically transferred to nitro-
cellulose membranes, pre-incubated in binding bu¡er
(PBS/3% BSA) and incubated with anti-phosphotyr-
osine antibody (UBI 4G10, 400 ng/ml). Immunoreac-
tive bands were detected using the ECL system
(Amersham) on FUJI RX ¢lm, and bands were
quantitated by densitometric scanning using a com-
puter assisted analysis program (Scan analysis, Bio-
soft).
2.7. Statistics
Variables measured were evaluated using the para-
metric Student’s t test.
3. Results
In order to analyze the lipid e¡ects on insulin re-
ceptor signaling in the HepG2 cell line, we added
exogenous lipids including linoeate (LA), eicosapen-
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taenoate (EPA) or cholesterol hemisuccinate (CHS)
to the culture media. To verify that these lipids were
incorporated into and metabolized by the cells, we
characterized the lipid modi¢cations by analyzing the
total lipid composition and measuring the global
membrane £uidity of these cells.
3.1. Global lipid composition in HepG2 before and
after treatment with LA, EPA or CHS
Table 1 shows the modi¢cations in HepG2 lipid
composition in the presence of the di¡erent lipids
tested. Total lipid composition was analyzed after
two cell passages in the presence of the exogenous
lipid (Table 1). The cholesterol/phospholipid ratio
was identical, near 0.2 in control and lipid-treated
cells. However, the phospholipid/protein ratio and
the cholesterol/protein ratio were altered approxi-
mately by 2 in CHS-treated cells as compared to
control cells. These same ratios were reduced by
0.7 approximately in LA-treated cells as compared
to control cells. No changes were observed with
EPA treatment. Lipid incorporation was also meas-
ured for the various classes of lipids: phosphatidyl-
choline (PC), phosphatidylinositol (PI), phospha-
tidylserine (PS), phosphatidylethanolamine (PE),
esteri¢ed cholesterol and triglycerides (TG) (Table
2). The analysis of cellular lipid fatty acid composi-
tion revealed that incorporation of fatty acids was
dependent on the added fatty acid and the lipid class
Table 1
Lipid composition of HepG2 cells after lipid treatment
Control LA, 18:2 EPA, 20:5 CHS
Phospholipids/proteins (Wg/mg protein) 340 þ 5 270 260 530
Cholesterol/proteins (Wg/mg protein) 39 þ 5.7 28.9 32.8 55.4
Cholesterol/phospholipids (mol/mol) 0.20 þ 0.03 0.21 0.28 0.23
Cells were grown for two to four passages in culture medium (DMEM/10% FBS) supplemented with linoleic acid (LA, 18:2, 1034
M), eicosapentaenoic acid (EPA, 20:5, 1035 M) or cholesterol hemisuccinate (CHS, 1034 M). Total lipid composition and ratio were
calculated and compared to cells grown in DMEM/10% FBS (control). Means and standard deviations are given for control cells and
result from four independent experiments. Data for treated cells are the means of two separate experiments except for LA-treatment
where only one experiment was performed.
Fig. 1. Lipid e¡ects on membrane £uidity in control and treated HepG2 cells. Membrane £uidity was estimated by the anisotropy of
£uorescence of two probes according to the protocol described in Section 2. (A) Fluorescence anisotropy from TMA-DPH. (B) Fluo-
rescence anisotropy from DPH. Concentrations of the lipids used are indicated in parentheses. Three dishes per treatment were ana-
lyzed. The results are shown as the mean þ S.D. obtained from three separate experiments. **Signi¢cantly di¡erent (P6 0.01) as com-
pared to the corresponding values obtained for control cells.
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as previously shown by Fujiyama-Fujirawa et al.
[27]. In the case of 1034 M LA treatment, amounts
of (n^6) fatty acids were increased by 100% for all
the lipids, except for PI where this increase was lower
(64%) or for TG where this increase was much higher
(500%). In the case of EPA treatment, changes were
also observed for PC, PS, PI, PE and CE, where the
(n^3) amounts increased, respectively, by 250, 170,
170, 240 and 200%. Surprisingly, cholesterol addition
also modi¢ed the amounts of fatty acids in the (n^3)
amount of PS which increased by 150%. It should be
noted that increased levels of polyunsaturated fatty
acids were generally seen in conjunction with a de-
crease in monounsaturated fatty acids.
Table 2
Fatty acids, cholesterol and triglyceride content of control and lipid-treated cells
Control LA EPA CHS
Phosphatidylcholine (PC)
g monosaturated 37.2 þ 3.5 20.9 33.3 35.2
g (n^6) 12.0 þ 1.4 25.0 11.7 13.9
g (n^3) 1.9 þ 0.4 2.4 4.7 2.1
g saturated 48.9 þ 2.7 51.8 55.4 47.8
Phosphatidylinositol (PI)
r monosaturated 33.0 þ 4.4 21.5 25.9 34.9
g (n^6) 24.5 þ 1.9 38.3 27.7 25.7
g (n^3) 3.3 þ 0.7 2.2 5.7 3.4
g saturated 36.2 þ 2.2 37.9 41.0 36.3
Phosphatidylserine (PS)
g monosaturated 36.7 þ 2.0 26.3 33.7 30.9
g (n^6) 14.3 þ 1.7 27.2 9.6 11.2
g (n^3) 10.7 þ 1.5 8.8 18.9 15.8
g saturated 38.5 þ 1.1 36.6 38.0 41.8
Phosphatidyl ethanolamine (PE)
g monosaturated 37.5 þ 1.5 22.8 26.4 36.9
g (n^6) 21.0 þ 5.5 44.1 17.8 21.5
g (n^3) 7.1 þ 1.8 3.3 16.8 5.8
g saturated 29.4 þ 2.4 29.7 30.4 25.4
Cholesterol esters
g monosaturated 50.1 þ 1.7 45.7 43.0 44.3
g (n^6) 10.0 þ 1.4 22.3 14.9 9.5
g (n^3) 3.2 þ 0.9 2.9 6.7 2.9
g saturated 36.8 þ 2.9 31.4 35.6 38.8
Triglycerides
g monosaturated 45.9 þ 3.7 38.6 38.1 47.0
g (n^6) 4.6 þ 1.5 22.8 7.5 6.3
g (n^3) 0.8 þ 0.3 1.8 13.7 1.8
g saturated 48.7 þ 4.8 38.7 40.8 45.1
Cells were incubated for two to passages in DMEM/10% FBS containing linoleic acid (LA, 18:2, 1034 M), eicosapentaenoic acid
(EPA, 20:5, 1035 M) or cholesterol hemisuccinate (CHS, 1034 M). The cell lipids were then extracted and the individual lipid species
were isolated by HPLC (see Section 2). Data are expressed as the mol% distribution of fatty acid. Means and standard deviations are
given for control cells and result from four independent experiments. Data for treated cells are the means of two separate experiments
except for LA treatment where only one experiment was performed. Boldface numbers are of signi¢cance relevance.
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3.2. Modi¢cations in HepG2 lipid composition led to
changes in membrane £uidity
As the lipid composition was modi¢ed, membrane
£uidity was tested for control and lipid-treated cells.
Fluorescence anisotropy with two probes; trimethyl-
ammonium diphenylhexatriene (TMA-DPH, 1 WM)
and diphenylhexatriene (DPH, 1 WM) was performed
on cell suspensions. DPH is incorporated into all
membranes (plasma membranes and cellular mem-
branes), TMA-DPH only inserts into the outer lea£et
of the plasma membrane. Fig. 1 illustrates the e¡ect
of the di¡erent lipids tested, at two ¢nal concentra-
tions: 1034 and 1035 M, on membrane £uidity.
In the case of fatty acid supplementation, we ob-
served, except for LA (1034 M)-treated cells, an in-
crease in the £uorescence anisotropy which means a
decrease in membrane £uidity suggesting that the
cells compensated for the incorporation of ‘£uidiz-
ing’ fatty acid by membrane reorganization. An in-
crease in £uorescence anisotropy was observed as
expected in the case of CHS treatment, indicating a
less £uid state at the plasma membrane (TMA-DPH,
Fig. 1A) and whole membrane (DPH, Fig. 1B) levels.
These results demonstrate that membrane £uidity
was modi¢ed in cells treated with lipids or CHS as
compared to control cells grown in 10% serum.
Moreover, the results indicate that the lipids were
incorporated into all cell membranes and induced
changes in membrane organization.
3.3. Insulin-induced glycogen synthesis is a¡ected by
lipids
Insulin is an anabolic hormone that stimulates
glycogen synthesis [15]. The e¡ect of insulin on
[14C]glucose incorporation into glycogen was ana-
lyzed in normal and lipid-treated cells. Basal levels
of [14C]glucose incorporation in LA- and EPA-
treated cells were lower than in control cells (78 þ 2
for LA and 67 þ 2 for EPA versus 100 þ 1). Basal
levels for CHS-treated cells were higher compared
to control cells (120 þ 4 versus 100 þ 1).
Insulin dose^response curves for control, CHS-,
LA- and EPA-treated cells were obtained and plotted
in Fig. 2. In control cells (control, cultivated in 10%
FBS), insulin induced a dose-dependent increase in
glycogen synthesis. The maximal increase in glycogen
synthesis, observed at 1038 M insulin, was about 1.4
over the basal level (Fig. 2). CHS-treated cells exhib-
ited a maximal e¡ect (1.15-fold increase) at a much
lower insulin concentration (about 10311 M insulin
as compared to 1038 M for control cells). LA- and
EPA-treated cells showed a maximal e¡ect (1.4- and
1.3-fold increase, respectively) at an insulin concen-
tration of 1039 M.
3.4. Lipids e¡ects on insulin receptor signaling
Since exogenously added lipids modi¢ed insulin-
stimulated glycogenesis, it was of interest to deter-
mine if the modulation of the biological event was
due to a modi¢cation in insulin receptor signaling.
Hence, lipids e¡ects on the insulin receptor were an-
alyzed at di¡erent molecular levels. Insulin binding
to the receptor, insulin receptor autophosphorylation
and subsequent intracellular phosphorylation, spe-
cially IRS-1 phosphorylation, were investigated.
Fig. 2. Lipids e¡ects on glycogen synthesis in normal and
treated HepG2 cells. Control and lipid-treated cells were plated
on 12 well-plates in DMEM/10% FCS and transferred into
DMEM 16 h prior to insulin stimulation. Cells (control cells,
a ; cells treated with CHS, b ; cells treated with EPA, S ; and
cells treated with LA, P) were incubated with di¡erent concen-
trations of insulin and glycogen synthesis was determined. A to-
tal of seven experiments, each in triplicate, was performed. The
results are shown as the mean þ S.D. obtained from the inde-
pendent experiments. *Signi¢cantly di¡erent (P6 0.05) as com-
pared to the corresponding values obtained for control cells.
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3.4.1. Insulin binding
Competition binding curves were performed for
control and lipid-treated cells (Table 3). Character-
istics of [125I]insulin binding as determined by
Scatchard analysis and the results obtained for con-
trol and lipid-treated cells were summed up in Table
3. All binding characteristics (inhibitory concentra-
tion and the maximal binding, IC50 and B0, respec-
tively) were calculated. No di¡erences were observed
in lipid-treated cells as compared to control cells.
Binding curves, obtained for control and lipid-
treated cells, were similar. This indicated that recep-
tor^ligand interaction was not altered by lipid mod-
i¢cation. The next step was to examine the receptor
autophosphorylation.
3.4.2. Insulin receptor autophosphorylation is a¡ected
by lipids
Tyrosine phosphorylation of the IR autophos-
phorylation and of cellular substrates occurs after
ligand binding and receptor dimerization. Insulin re-
ceptor autophosphorylation in control and lipid-
treated cells was studied at di¡erent time points
upon 0.1 WM insulin stimulation. Analysis and
semi-quanti¢cation of the IR autophosphorylation
was performed on Western blots. Equal amounts of
protein extracts were run on a 7.5% SDS-PAGE gel
and tyrosine phosphorylated proteins were detected
by chemiluminescence using antiphosphotyrosine
antibodies. The phosphorylated band at 95 kDa
seen upon insulin stimulation, corresponds with the
molecular weight of the L-subunit of the IR (Fig. 3A,Fig. 3. Lipids e¡ects on insulin receptor autophosphorylation in
control and treated HepG2 cells. (A) Tyrosine phosphorylation
in whole-cell extracts from control and treated HepG2 cells.
HepG2 cells (control; CHS-treated; LA; and EPA) were stimu-
lated for the indicated times (0, 1 and 5 min) with 0.1 WM insu-
lin (hatched bars). Cellular extracts were electrophoresed, trans-
ferred to nitrocellulose, and tyrosine-phosphorylated proteins
were revealed with anti-phosphotyrosine antibodies and a per-
oxidase-coupled staining method. The arrow indicates the 95-
kDa subunit of the insulin receptor. (B) Insulin receptor auto-
phosphorylation was analyzed in control and treated cells. The
95-kDa band corresponding to the L-subunit of the insulin re-
ceptors was quantitated by densitometric scanning. Results are
depicted as mean þ S.D. of four separate experiments.
aSigni¢cant di¡erences (P6 0.05) between stimulated cells and
control cells. bSigni¢cant di¡erences (P6 0.05) between lipid-
treated and the corresponding control situation without lipid
(control cells).
Fig. 4. Lipids e¡ects on IRS-1 phosphorylation in normal and
treated HepG2 cells. Insulin receptor substrate-1 (IRS-1) phos-
phorylation was analyzed in normal and treated cells. The band
at 180 kDa corresponding to the protein was quantitated by
densitometric scanning. Results are depicted as mean þ S.D. of
four separate experiments. aSigni¢cant di¡erences (P6 0.05) be-
tween stimulated cells and control cells. bSigni¢cant di¡erences
(P6 0.05) between lipid-treated and the corresponding control
situation without lipid (control cells).
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arrow) [28]. Note the di¡erence in phosphorylation
intensity of the receptor in CHS and lipid-treated
cells as compared to control cells.
Fig. 3B summarizes the data obtained after densi-
tometric analysis of the insulin receptor L-subunit.
Maximal tyrosine phosphorylation of the receptor
in LA- and EPA lipid-treated cells and control cells
was observed after 5 min with 0.1 WM insulin. How-
ever, the kinetics of IR phosphorylation appeared to
be slowed down in EPA-treated cells. The value ob-
tained at 30 s was lower than those observed for
control or LA-treated cells. In CHS-treated cells,
basal phosphorylation was higher than in the control
cells. Maximal phosphorylation of the receptor was
obtained after 5 min; however, it was decreased by
50% as compared to control cells. This result indi-
cates that the receptor kinase activity was inhibited
in the presence of CHS.
Taken together, these results show a correlation
with the lipid-e¡ects on [14C]glucose incorporation
into glycogen.
3.4.3. Insulin receptor substrate-1 phosphorylation
Insulin receptor substrate-1 (IRS-1) is phospho-
rylated by activated IR upon insulin stimulation
[29]. After densitometric analysis of the 185-kDa
band corresponding to IRS-1 from several Western
blots, we obtained the graph illustrated in Fig. 4. For
each treatment, the basal level of IRS-1 phosphoryl-
ation were diminished as compared to control cells.
EPA and LA treatments induced a delayed increase
in IRS-1 phosphorylation. In the presence of CHS,
IRS-1 phosphorylation was inhibited, which is
compatible with IR kinase inhibition. The time
course of tyrosine phosphorylation of IRS-1 was
altered in the presence of the lipids as was the IR
kinase activity.
4. Discussion
Changes in cell membrane lipid composition have
been described in several pathological conditions, in-
cluding diabetes and cancer [18^20,30]. Hence, alter-
ing cell membrane lipid composition and analyzing
how these changes a¡ect the cell, will increase our
understanding of related pathological conditions.
Lipid-treated cells represent one model that can be
used to analyze lipid disorders and their e¡ects on
intracellular signaling. To mimic lipid alterations ob-
served in clinical pathologies, we treated a human
hepatoma cell line (HepG2) with di¡erent classes of
lipids: EPA (n^3) representing the ‘oil-lipid’ class,
LA (n^6) representing the ‘corn oil’ class and choles-
terol (CHS). Analysis of lipid composition of lipid-
treated HepG2 cells, as compared to control cells,
indicated that treated HepG2 cells incorporated, se-
lectively in regard to the lipid classes, EPA, LA and
CHS into their membranes. Membrane £uidity of
intact cells, which also indicates lipid incorporation,
was determined using £uorescence anisotropy of
TMA-DPH and DPH in both control and lipid-
treated cells. Furthermore, as a result of their incor-
poration and metabolization, exogenous EPA, LA or
CHS induced membrane perturbations and an over-
all global modi¢cation of lipid pattern in HepG2
cells. It should be noted that cells compensated for
lipid incorporation. The £uidi¢cation expected after
(n^3) and (n^6) lipid treatments was not as high as
expected, due to a partial rigidi¢cation. Treated cells
compensated by generating more desaturated fatty
acids when saturated lipids were added into the cul-
ture media and incorporated and/or metabolized
(Table 2).
As membrane £uidity and global lipid composition
were altered in HepG2 cells, the next step was to
determine if these changes a¡ected insulin receptor
signaling pathways and insulin-stimulated glucose in-
corporation into glycogen. Insulin-stimulated glucose
incorporation into glycogen was low, as is often the
case for hepatoma cells. This may be due in part to
the use of high glucose culture medium, required for
maximal expression of insulin receptors in HepG2
Table 3
Lipid e¡ects on insulin binding in control and lipid-treated cells
Treatment IC50 (nM) B0 (%)
Control 1.28 þ 0.40 100
LA, 18:2 1.12 þ 0.16 92 þ 15
EPA, 20:5 1.16 þ 0.23 118 þ 11
CHS 1.60 þ 0.36 109 þ 9
Cells were incubated with di¡erent insulin concentrations and
equal amount of radiolabeled insulin for 16 h at 4‡C. Speci¢c
bound radioactivity was counted in a gamma counter. The
data, expressed as percentage relative to control cells, represent
the mean þ S.D. of three separate experiments.
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cells [31]. Nevertheless, the HepG2 cell line still was a
good model for our study considering that these cells
retained the major characteristics of a hepatoma [16].
Glycogen synthesis was di¡erentially modi¢ed by
EPA, LA and CHS. Treatment with EPA and LA
showed a decrease in glycogen synthesis as compared
to control. Although biphasic dose^response curves
are not common, they have been described for other
signaling systems, as well as for insulin-sensitive sys-
tems [32,33]. Since glucose incorporation into glyco-
gen, upon insulin stimulation, was a¡ected by lipid
alteration, it was likely that insulin signaling path-
ways were modulated by the presence of the lipids.
Therefore, the e¡ects of lipid treatment on the insulin
receptor were examined at a molecular level. Insulin
binding to the receptor was analyzed ¢rst. EPA, LA
and CHS did not a¡ect insulin binding to the recep-
tor. Although, in some cases, lipid alteration has
resulted in increased insulin binding to the receptor
[34], this study agrees with the work of several labo-
ratories, where insulin binding was not modulated by
lipids [35,36]. Previous work from our laboratory
with insulin receptors reconstituted in lipid vesicles
has also shown that insulin binding is not a¡ected by
lipids [7].
Although insulin binding to its receptor was not
a¡ected by lipid treatment, in this study the kinetics
of insulin receptor autophosphorylation were modi-
¢ed (Fig. 4). Other studies have also demonstrated
an in£uence of lipid composition on insulin receptor
tyrosine kinase activity [37,38]. In particular, Leray
and collaborators showed that the tyrosine kinase
activity for reconstituted IRs in lipid vesicles, was
sensitive to almost all lipids tested [7]. This in vitro
study suggested the presence of a lipid micro-domain
around the receptor. The composition of this domain
could play an important role for insulin signaling via
its transmembrane receptor. Our work from this
study, in combination with results from a previous
study done with cultured rat hepatoma cells (ZHC)
[8], also suggests the existence of a speci¢c lipid en-
vironment or microdomain around the insulin recep-
tor. Indeed, we have shown that supplementing the
growth media of cultured ZHC with linoleic acid and
25-hydroxy-cholesterol diminished cell responsive-
ness to insulin stimulated insulin receptor autophos-
phorylation and reduced the phosphorylation of
exogenous substrates [10]. When comparing the re-
sults from this study, done with HepG2 cells, with
the results from the work on ZHC cells, we noted
several di¡erences in insulin receptor phosphoryla-
tion and biological events downstream in the signal-
ing pathways. Since global lipid composition of non-
treated ZHC and HepG2 cells were initially di¡erent,
the observed di¡erences were not unexpected. These
di¡erences suggest the possibility that a speci¢c lipid
environment is necessary for full IR kinase activity.
Overall, these studies suggest that lipid composi-
tion may alter the activity of the insulin receptor
and/or modulate the accessibility of its substrates.
These observations could result from membrane per-
turbations or the disruption of plasma membrane
microdomains involved in signal transduction. In
the membrane, microdomains may play a key role
in signal transduction [39] because proteins involved
in di¡erent signaling pathways have been described
to be membrane dependent as in the case of Ras.
This p21 kDa protein is involved in receptor tyrosine
kinase transduction [40] and is farnesylated. Lipid
incorporation into HepG2 cells could a¡ect the ac-
tivity of this protein. One di⁄culty in correlating
downstream biological events to the modulation of
the insulin receptor might be due to several destabil-
izations of lipid microdomains in an organized plas-
ma membrane. Understanding these phenomenon
could be of relevant importance when analyzing lipid
e¡ects on receptor tyrosine kinase signaling related
to di¡erent pathological conditions.
In conclusion, we have developed a cellular model
in which cell membrane lipid alterations may be in-
vestigated. Lipid modi¢cations induced changes in
membrane £uidity and modulated insulin receptor
kinase activity and phosphorylation of intracellular
substrates of the insulin receptor. Downstream
events, i.e. glycogen synthesis, were also a¡ected by
the presence of exogenously added lipids. The results
suggest an approach that can be used to study the
role of n^3 and n^6 lipids in pathological processes,
such as diabetes and other pathology related to lipid
disorders.
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